HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Hsiao Selected Research

Peptides (Polypeptides)

1/2020PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.
9/2019Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival.
2/2018Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.
7/2015DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
1/2008Observation of peptide differences between cancer and control in gastric juice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Hsiao Research Topics

Disease

189Neoplasms (Cancer)
05/2024 - 01/2002
77Neoplasm Metastasis (Metastasis)
05/2024 - 01/2003
42Lung Neoplasms (Lung Cancer)
05/2024 - 01/2002
25Carcinogenesis
01/2023 - 04/2009
22Squamous Cell Carcinoma of Head and Neck
01/2024 - 04/2009
17Mouth Neoplasms (Oral Cancer)
10/2023 - 06/2008
16Breast Neoplasms (Breast Cancer)
05/2024 - 05/2003
15Prostatic Neoplasms (Prostate Cancer)
01/2024 - 09/2014
14Glioblastoma (Glioblastoma Multiforme)
05/2024 - 02/2014
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 07/2011
14Hepatocellular Carcinoma (Hepatoma)
10/2021 - 05/2009
13Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2013
10Hypertension (High Blood Pressure)
11/2023 - 03/2010
9Stomach Neoplasms (Stomach Cancer)
11/2023 - 11/2003
9Adenocarcinoma of Lung
12/2022 - 01/2013
8Renal Cell Carcinoma (Grawitz Tumor)
08/2023 - 09/2015
8Glioma (Gliomas)
09/2019 - 02/2005
7Inflammation (Inflammations)
11/2020 - 03/2007
6Triple Negative Breast Neoplasms
05/2024 - 03/2015
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 07/2015
6Adenocarcinoma
11/2021 - 11/2003
5Cholangiocarcinoma
01/2022 - 01/2017
5Colonic Neoplasms (Colon Cancer)
07/2021 - 01/2017
5Disease Progression
01/2019 - 06/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 10/2011
4Hyperthermia
11/2022 - 05/2013
4Esophageal Neoplasms (Esophageal Cancer)
11/2022 - 09/2009
4Infections
12/2019 - 01/2004
4Hypoxia (Hypoxemia)
01/2019 - 03/2013
4Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2015 - 12/2009

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2007
24Biomarkers (Surrogate Marker)IBA
12/2022 - 02/2007
19CateninsIBA
01/2022 - 09/2012
17MicroRNAs (MicroRNA)IBA
05/2024 - 05/2009
14EnzymesIBA
05/2024 - 03/2007
10Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 03/2010
9Cisplatin (Platino)FDA LinkGeneric
10/2021 - 09/2009
8Fructose-Bisphosphate Aldolase (Aldolase)IBA
05/2024 - 01/2016
8RNA (Ribonucleic Acid)IBA
01/2023 - 07/2015
8Interleukin-6 (Interleukin 6)IBA
11/2020 - 06/2002
7LigandsIBA
11/2023 - 09/2009
7CytokinesIBA
01/2023 - 01/2003
7Matrix Metalloproteinases (MMPs)IBA
01/2023 - 01/2003
7Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2017
6IronIBA
05/2024 - 06/2021
6FructoseIBA
11/2023 - 06/2014
6AndrogensIBA
01/2023 - 08/2015
6Small Interfering RNA (siRNA)IBA
10/2020 - 08/2010
5Metalloproteases (Metalloproteinases)IBA
01/2024 - 05/2009
5FlavonoidsIBA
01/2024 - 07/2015
5AntioxidantsIBA
11/2023 - 10/2013
5PlatinumIBA
01/2022 - 01/2013
5AntibodiesIBA
12/2021 - 02/2014
5Messenger RNA (mRNA)IBA
05/2021 - 04/2009
5Histone MethyltransferasesIBA
05/2021 - 10/2010
5Peptides (Polypeptides)IBA
01/2020 - 01/2008
5Cadherins (E-Cadherin)IBA
08/2019 - 11/2003
5DNA (Deoxyribonucleic Acid)IBA
12/2016 - 02/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 01/2004
4Caspase 3 (Caspase-3)IBA
11/2023 - 06/2009
4Transferrin (beta 2 Transferrin)IBA
10/2023 - 09/2011
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2023 - 09/2009
4Androgen Receptors (Androgen Receptor)IBA
01/2023 - 01/2020
4Proteoglycans (Proteoglycan)IBA
01/2023 - 06/2019
4AcetyltransferasesIBA
11/2022 - 02/2011
4Focal Adhesion Protein-Tyrosine KinasesIBA
08/2022 - 01/2019
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2022 - 06/2016
4Antipsychotic Agents (Antipsychotics)IBA
06/2022 - 12/2012
4Adenosine Triphosphate (ATP)IBA
06/2022 - 01/2018
4Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2017
4ErbB Receptors (EGF Receptor)IBA
10/2021 - 12/2013
4Paclitaxel (Taxol)FDA LinkGeneric
11/2020 - 11/2011
4Phosphotransferases (Kinase)IBA
10/2020 - 01/2013
4Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2020 - 01/2003
4ovatodiolideIBA
01/2020 - 01/2017
4Vascular Endothelial Growth Factor CIBA
11/2014 - 12/2009
3Temozolomide (Temodar)FDA LinkGeneric
05/2024 - 08/2019
3Long Noncoding RNAIBA
05/2024 - 02/2016
3DisintegrinsIBA
01/2024 - 05/2009
3ApigeninIBA
01/2024 - 08/2018
3GemcitabineFDA Link
10/2023 - 01/2017
3LipidsIBA
10/2023 - 09/2014
3Therapeutic UsesIBA
10/2023 - 11/2015
3GoldIBA
10/2023 - 05/2013
3cyclic 3',5'-thymidine monophosphate (cTMP)IBA
01/2023 - 10/2013
3CarbohydratesIBA
12/2022 - 01/2020
3Sirtuin 1IBA
06/2022 - 03/2013
3Penfluridol (Semap)IBA
06/2022 - 01/2019
3Pyruvate KinaseIBA
01/2022 - 01/2018
3CollagenIBA
10/2021 - 06/2006

Therapy/Procedure

64Therapeutics
05/2024 - 09/2009
21Drug Therapy (Chemotherapy)
10/2023 - 01/2011
7Precision Medicine
02/2022 - 09/2017
6Radiotherapy
01/2022 - 03/2012
5Photochemotherapy (Photodynamic Therapy)
10/2023 - 07/2014
4Castration
01/2023 - 01/2021
3Lasers (Laser)
05/2024 - 10/2016
3Photothermal Therapy
03/2024 - 05/2013
3Intravenous Injections
03/2022 - 01/2003